Titre : Acides lévuliniques

Acides lévuliniques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Methicillin-Resistant Staphylococcus aureus
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Acides lévuliniques : Questions médicales les plus fréquentes", "headline": "Acides lévuliniques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Acides lévuliniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-12", "dateModified": "2025-02-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Acides lévuliniques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cétoacides", "url": "https://questionsmedicales.fr/mesh/D007651", "about": { "@type": "MedicalCondition", "name": "Cétoacides", "code": { "@type": "MedicalCode", "code": "D007651", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.241.755" } } }, "about": { "@type": "MedicalCondition", "name": "Acides lévuliniques", "alternateName": "Levulinic Acids", "code": { "@type": "MedicalCode", "code": "D007982", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Kyoungseon Min", "url": "https://questionsmedicales.fr/author/Kyoungseon%20Min", "affiliation": { "@type": "Organization", "name": "Gwangju Clean Energy Research Center, Korea Institute of Energy Research (KIER), Gwangju 61003, Republic of Korea. Electronic address: min4605@kier.re.kr." } }, { "@type": "Person", "name": "Zhihao Yu", "url": "https://questionsmedicales.fr/author/Zhihao%20Yu", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } }, { "@type": "Person", "name": "Xuebin Lu", "url": "https://questionsmedicales.fr/author/Xuebin%20Lu", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } }, { "@type": "Person", "name": "Jian Xiong", "url": "https://questionsmedicales.fr/author/Jian%20Xiong", "affiliation": { "@type": "Organization", "name": "Department of Chemistry & Environmental Science, School of Science, Tibet University, Lhasa, 850000, P. R. China." } }, { "@type": "Person", "name": "Na Ji", "url": "https://questionsmedicales.fr/author/Na%20Ji", "affiliation": { "@type": "Organization", "name": "School of Environmental Science and Engineering, Tianjin Key Laboratory of Biomass/Wastes Utilization, Tianjin University, Tianjin, 300350, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Methicillin-resistant Staphylococcus aureus-associated orbital cellulitis: a case series.", "datePublished": "2023-04-07", "url": "https://questionsmedicales.fr/article/37029211", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10792-023-02698-y" } }, { "@type": "ScholarlyArticle", "name": "Mptx2 defends against peritoneal infection by methicillin-resistant staphylococcus aureus.", "datePublished": "2022-05-21", "url": "https://questionsmedicales.fr/article/35609377", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2022.108856" } }, { "@type": "ScholarlyArticle", "name": "Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.", "datePublished": "2024-10-10", "url": "https://questionsmedicales.fr/article/39390563", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13052-024-01780-0" } }, { "@type": "ScholarlyArticle", "name": "[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].", "datePublished": "2024-01-22", "url": "https://questionsmedicales.fr/article/38245868", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.37201/req/113.2023" } }, { "@type": "ScholarlyArticle", "name": "Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36371648", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/phar.2741" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Acides carboxyliques", "item": "https://questionsmedicales.fr/mesh/D002264" }, { "@type": "ListItem", "position": 4, "name": "Cétoacides", "item": "https://questionsmedicales.fr/mesh/D007651" }, { "@type": "ListItem", "position": 5, "name": "Acides lévuliniques", "item": "https://questionsmedicales.fr/mesh/D007982" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Acides lévuliniques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Acides lévuliniques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Acides lévuliniques", "description": "Comment diagnostiquer une intoxication aux acides lévuliniques ?\nQuels tests sont utilisés pour détecter les acides lévuliniques ?\nQuels symptômes indiquent une exposition aux acides lévuliniques ?\nY a-t-il des marqueurs biologiques pour les acides lévuliniques ?\nLes tests d'imagerie sont-ils utiles pour les acides lévuliniques ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Acides lévuliniques", "description": "Quels sont les symptômes courants d'une exposition ?\nLes acides lévuliniques provoquent-ils des allergies ?\nY a-t-il des effets à long terme d'une exposition ?\nLes symptômes varient-ils selon la dose ?\nLes enfants sont-ils plus sensibles aux acides lévuliniques ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Acides lévuliniques", "description": "Comment prévenir l'exposition aux acides lévuliniques ?\nLes travailleurs doivent-ils être formés ?\nDes équipements de protection sont-ils nécessaires ?\nY a-t-il des réglementations sur leur utilisation ?\nLes fuites doivent-elles être signalées ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Acides lévuliniques", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les acides lévuliniques ?\nComment traiter les irritations cutanées causées ?\nLes soins d'urgence sont-ils nécessaires ?\nLa détoxification est-elle recommandée ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Acides lévuliniques", "description": "Quelles complications peuvent survenir après exposition ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de cancer liés aux acides lévuliniques ?\nLes complications peuvent-elles affecter la santé mentale ?\nDes soins de suivi sont-ils nécessaires après exposition ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Acides lévuliniques", "description": "Qui est le plus à risque d'exposition ?\nL'âge influence-t-il la sensibilité ?\nLes personnes allergiques sont-elles plus à risque ?\nY a-t-il des prédispositions génétiques ?\nLes conditions de santé préexistantes augmentent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D007982?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux acides lévuliniques ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les acides lévuliniques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour mesurer les niveaux d'acides." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux acides lévuliniques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des nausées, des vertiges et des douleurs abdominales peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les acides lévuliniques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de marqueurs biologiques spécifiques pour ces acides." } }, { "@type": "Question", "name": "Les tests d'imagerie sont-ils utiles pour les acides lévuliniques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les tests d'imagerie ne sont généralement pas utilisés pour diagnostiquer l'exposition." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une exposition ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées." } }, { "@type": "Question", "name": "Les acides lévuliniques provoquent-ils des allergies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent développer des réactions allergiques à ces acides." } }, { "@type": "Question", "name": "Y a-t-il des effets à long terme d'une exposition ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut entraîner des problèmes respiratoires et cutanés." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Les enfants sont-ils plus sensibles aux acides lévuliniques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques de ces acides." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux acides lévuliniques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits contenant des acides lévuliniques et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et la manipulation sécurisée est essentielle pour les travailleurs." } }, { "@type": "Question", "name": "Des équipements de protection sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des gants et des masques doivent être portés lors de la manipulation de ces acides." } }, { "@type": "Question", "name": "Y a-t-il des réglementations sur leur utilisation ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réglementations strictes encadrent l'utilisation des acides lévuliniques dans l'industrie." } }, { "@type": "Question", "name": "Les fuites doivent-elles être signalées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, toute fuite ou déversement doit être signalé immédiatement aux autorités compétentes." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste principalement à éliminer l'exposition et à gérer les symptômes." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les acides lévuliniques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique pour l'intoxication aux acides lévuliniques." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les irritations cutanées peuvent être traitées avec des crèmes apaisantes et des antihistaminiques." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des soins d'urgence peuvent être nécessaires en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "La détoxification est-elle recommandée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La détoxification n'est généralement pas nécessaire, mais une surveillance médicale est conseillée." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des troubles respiratoires ou des dermatites peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des complications sont réversibles avec un traitement approprié et rapide." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés aux acides lévuliniques ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de preuves concluantes liant ces acides à un risque accru de cancer." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la santé mentale ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications physiques peuvent entraîner des effets sur la santé mentale, comme l'anxiété." } }, { "@type": "Question", "name": "Des soins de suivi sont-ils nécessaires après exposition ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical est recommandé pour surveiller d'éventuelles complications tardives." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique sont les plus à risque d'exposition aux acides." } }, { "@type": "Question", "name": "L'âge influence-t-il la sensibilité ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus sensibles aux effets toxiques." } }, { "@type": "Question", "name": "Les personnes allergiques sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes ayant des antécédents d'allergies peuvent être plus sensibles aux acides." } }, { "@type": "Question", "name": "Y a-t-il des prédispositions génétiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines prédispositions génétiques peuvent influencer la sensibilité aux toxines." } }, { "@type": "Question", "name": "Les conditions de santé préexistantes augmentent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions comme l'asthme ou des maladies cutanées peuvent augmenter le risque." } } ] } ] }

Sources (10000 au total)

Methicillin-resistant Staphylococcus aureus-associated orbital cellulitis: a case series.

In recent years, methicillin-resistant Staphylococcus aureus (MRSA) orbital cellulitis (OC) has drawn increasing clinical and public health concern. We present a case series of MRSA OC encountered at ... A multi-centre retrospective case series investigating MRSA OC in Australia from 2013 to 2022. Patients of all ages were included.... Nine cases of culture-positive non-multi-resistant MRSA (nmMRSA) OC were identified at four tertiary institutions across Australia (7 male, 2 female). Mean age was 17.1 ± 16.7 years (range 13-days to ... NMMRSA OC can follow an aggressive clinical course causing severe orbital and intracranial complications across a wide demographic. However, early recognition, initiation of targeted antibiotics and s...

Predictors of Methicillin-resistant Staphylococcus aureus infection in children with acute osteomyelitis.

This study aims to identify risk factors associated with Methicillin-resistant Staphylococcus aureus (MRSA) infection in children diagnosed with acute osteomyelitis (AO) and to elucidate the laborator... We conducted a retrospective analysis involving 123 children with acute osteomyelitis treated at our hospital. Upon admission, we measured white blood cell (WBC) counts, C-reactive protein (CRP) level... The MRSA group had a significantly higher average age compared to the non-MRSA group (P < 0.05). Notably, the incidence of suppurative arthritis was significantly lower in the MRSA group (P < 0.05). A... In children newly admitted with acute osteomyelitis, a CRP level exceeding 73.23 µg/mL may indicate a high likelihood of MRSA infection. For children with AO who have been hospitalized for three days ...

[Prevalence and risk factors for methicillin-resistant Staphylococcus aureus infection in children].

The objectives of this work were to know the prevalence of methicillin-resistant S. aureus (MRSA) infections in the paediatric population of our health department, to describe the risk factors for inf... A retrospective, descriptive and analytical study of infections produced by MRSA versus those produced by MSSA was carried out during the years 2014 to 2018. Risk factors for MRSA infection were studi... 162 patients with S. aureus infections were identified. Of these, 25 (15.4%) were MRSA. The highest percentages of MRSA infection occurred among children who required hospital admission (23.4%). In th... Our results suggest the need to review empirical local treatment regimen using drugs active against MRSA in infections of probable staphylococcal origin admitted to the hospital, especially if they ha...

Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia.

The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus... Single-center, retrospective cohort study between January 1, 2016, and December 31, 2021.... State University of New York Upstate University Hospital, a 748-bed tertiary care, academic medical center in Syracuse, NY.... Adult patients were included if they had blood cultures positive for MRSA ≥72 h, received vancomycin monotherapy initially, and received vancomycin plus ceftaroline for ≥24 h. Patients were excluded i... Patients were medically complex with a median Pitt bacteremia score of 3, 63.3% (19/30) were admitted to the intensive care unit, and 66.7% (20/30) had infective endocarditis. Vancomycin-associated ac... Vancomycin plus ceftaroline may represent an effective and well-tolerated salvage regimen option for persistent MRSAB....

Rate of methicillin-resistant Staphylococcus aureus in pediatric emergency departments in Spain.

Staphylococcus aureus is a common germ in bacterial infections in children. The rate of methicillin-resistant S. aureus (MRSA) is increasing lately.... The main aim is to know the rate of positive cultures to MRSA in Spanish pediatric emergency departments. The secondary aims are to analyse the risk factors for MRSA isolation (patient origin, history... Retrospective multicenter study (07/01/2017-06/30/2018) with review of patient histories with isolation of S. aureus in samples of any origin obtained in 8 pediatric emergency departments of the Infec... During this period, S. aureus was detected in 403 patients (average age 75.8 ± 59.2 months; 54.8% male): 28.8% hospital-related infections (HRI) and 71.2% community-related infections (CRI). Overall, ... The overall MRSA rate was one in 6 staphylococcal infections. Higher MRSA rates were detected in samples of suppurating skin injuries and in foreign children or in children with a history of previous ...

Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus.

We aimed to determine the synergistic effects of ceftaroline (CPT) in combination with daptomycin (DAP), vancomycin (VAN), or linezolid (LNZ) against various methicillin-resistant Staphylococcus aureu... MRSA strains randomly selected from 2014 to 2018 were studied. Checkerboard titration and in vitro time-kill analyses were used to determine the synergistic activities of the antibiotic combinations.... A total of 10 genetically distinct MRSA strains were included in this study. The checkerboard titration analysis revealed that the CPT-DAP, CPT-VAN, and CPT-LNZ combinations had a synergistic effect a... The CPT-DAP combination showed better synergistic activity than the CPT-VAN and CPT-LNZ combinations against the enrolled MRSA strains. DAP, rather than VAN or LNZ, might be a better choice for CPT co...

Using Methicillin-Resistant Staphylococcus aureus Nasal Screens to Rule Out Methicillin-Resistant S aureus Pneumonia in Surgical Intensive Care Units.

The methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) has a high negative predictive value (NPV). We aimed to understand if there was a difference in the NPV of the MR... We performed a single-center, retrospective cohort study of adults with a positive respiratory culture and MRSA nasal PCR admitted to a surgical ICU from 2016 to 2019. Patients were stratified by surg... We analyzed 61 patients: 42.6% (n = 26) ACS-ICU and 57.4% (n = 35) CVICU. There were no differences in age, comorbidities, prior MRSA infection, recent antibiotic use, immunocompromised status, or ren... The MRSA nasal PCR screen has a high NPV for ruling out MRSA pneumonia in critically ill surgical patients. However, patients in the CVICU and patients hospitalized ≥5 d had a longer time to de-escala...

Molecular epidemiology, virulence and antimicrobial resistance of Bulgarian methicillin resistant Staphylococcus aureus isolates.

Severe infections of virulent methicillin-resistant Staphylococcus aureus (MRSA) are a serious health problem. The present study aimed to investigate clonal spread, virulence and antimicrobial resista... Molecular identification and mecA gene detection were performed with PCR. Clonal relatedness was evaluated by RAPD PCR and MLST. MRSA epidemiology, virulence and resistance patterns were investigated ... All 27 isolates were identified as S. aureus and were mecA positive, and all were susceptible to linezolid, tigecycline and vancomycin. The toxin genes hlg (in 92.6% of isolates), seb (77.8%), sei (77... To the best of our knowledge, this study is the first describing the clonal spreading of Bulgarian MRSA and the association with their virulence and resistance determinants. Monitoring of MRSA epidemi...

Comparing Rates of Postoperative Meningitis After Endoscopic Endonasal Procedures Based on Methicillin-Resistant Staphylococcus aureus/Methicillin-Sensitive Staphylococcus aureus Colonization and Antibiotic Prophylaxis.

Endoscopic endonasal approach (EEA) procedures are inherently contaminated due to direct access through the nasopharyngeal mucosa. The reported rate of postoperative meningitis in EEA procedures is 0.... All adult patients who underwent EEA resection at our institution from 2013 to 2021 were retrospectively reviewed. Patients with preoperative cerebrospinal fluid infections were excluded. Data includi... Of 483 patients identified (mean age, 51 years; range, 18-90 years; 274 [56.7%] female), 80 (16.6%) had a positive preoperative methicillin-resistant Staphylococcus aureus (MRSA)/methicillin-sensitive... Postoperative rates of meningitis after EEA surgery were not significantly changed based on MRSA/MSSA colonization status of the patient or preoperative decolonization. The utility of preoperative tes...